Pfizer Inc (PFE.N)
42.99USD
26 Jun 2019
$-0.77 (-1.76%)
$43.76
$43.62
$43.79
$42.54
8,372,925
6,833,481
$46.46
$36.03
About
Overall
| Beta: | 0.65 |
| Market Cap(Mil.): | $243,302.50 |
| Shares Outstanding(Mil.): | 5,559.93 |
| Dividend: | 0.36 |
| Yield (%): | 3.29 |
Financials
| PFE.N | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 24.23 | 32.49 | 37.22 |
| EPS (TTM): | 1.81 | -- | -- |
| ROI: | 8.15 | 12.55 | 12.18 |
| ROE: | 16.55 | 13.86 | 17.03 |
RPT-BUZZ-U.S. stocks weekly: Asset grab
(Repeats from Friday. Updates chart) ** S&P 500 extends win streak to three weeks, adds 2.2%. Rate-cut euphoria and trade optimism spur index to record highs. Bonds and commodities also catch bids ** Indeed, studies suggested sudden quiet could end with a bang ** And as the SPX went for a second round with resistance , the Dow caught a second wind ** Now the Dow is trying to make the big leap as the SPX notched a "defensive" new high ** Every sector rises: Energy and tech s
BUZZ-U.S. stocks weekly: Asset grab
** S&P 500 extends win streak to three weeks, adds 2.2%. Rate-cut euphoria and trade optimism spur index to record highs. Bonds and commodities also catch bids ** Indeed, studies suggested sudden quiet could end with a bang ** And as the SPX went for a second round with resistance , the Dow caught a second wind ** Now the Dow is trying to make the big leap as the SPX notched a "defensive" new high ** Every sector rises: Energy and tech surge, while defensive sectors notch ga
GSK offers concessions to address EU concerns over Pfizer deal
BRUSSELS GlaxoSmithKline has offered concessions to address EU antitrust concerns over its planned joint venture with Pfizer's consumer health business, the European Commission said on Thursday.
GSK offers concessions to address EU concerns over Pfizer deal
BRUSSELS, June 20 GlaxoSmithKline has offered concessions to address EU antitrust concerns over its planned joint venture with Pfizer's consumer health business, the European Commission said on Thursday.
PRESS DIGEST - Wall Street Journal - June 18
June 18 The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy.
Pfizer makes $10.6 billion cancer bet in cash deal for Array Biopharma
Pfizer Inc said on Monday it would buy Array Biopharma Inc for $10.64 billion in cash, a deal it hopes will help make it a leader in colon cancer and build up its pipeline of oncology drugs.
Pfizer makes $10.6 billion cancer bet in cash deal for Array Biopharma
Pfizer Inc said on Monday it would buy Array Biopharma Inc for $10.64 billion in cash, a deal it hopes will help make it a leader in colon cancer and build up its pipeline of oncology drugs.
Faith in the Fed nudges Wall Street higher
Wall Street edged higher on Monday, supported by Facebook, Amazon and Apple, as investors awaited a key Federal Reserve meeting that is expected to lay the groundwork for an interest rate cut later this year. | Video
US STOCKS-Faith in the Fed nudges Wall Street higher
* Indexes end higher: Dow 0.09%, S&P 500 0.09%, Nasdaq 0.62% (Updated to close)
US STOCKS-Faith in the Fed pushes Wall Street higher
* Indexes up: Dow 0.17%, S&P 500 0.23%, Nasdaq 0.79% (Updated to afternoon)
Estimates